Skip to main content

Diagnostics & research Stocks - Companies, Performance & Financial Metrics

Browse 46 diagnostics & research stocks with financial metrics and performance data (Healthcare sector).

Diagnostics & research Stocks

46 stocks in the diagnostics & research industry. Click column headers to sort.

#
1
TMO logo
TMO
Thermo Fisher Scientific Inc.$572.32$213.48B$45.20B$6.86B$18.222.17M
2
DHR logo
DHR
Danaher Corporation$192.50$136.91B$24.78B$3.69B$5.175.34M
3
IDXX logo
IDXX
IDEXX Laboratories, Inc.$539.37$43.51B$4.45B$1.10B$13.56671.73K
4
A logo
A
Agilent Technologies, Inc.$139.74$39.69B$7.23B$1.41B$4.972.35M
5
NTRA logo
NTRA
Natera, Inc.$264.69$37.45B$2.50B-$226.31M$-1.641.44M
6
IQV logo
IQV
IQVIA Holdings Inc.$207.32$35.20B$16.63B$1.39B$8.071.41M
7
WAT logo
WAT
Waters Corporation$382.41$31.41B$3.77B$449.25M$6.88885.92K
8
ILMN logo
ILMN
Illumina, Inc.$196.86$30.32B$4.39B$853.00M$5.511.89M
9
MTD logo
MTD
Mettler-Toledo International Inc.$1,331.87$27.02B$4.09B$875.06M$42.66193.24K
10
DGX logo
DGX
Quest Diagnostics Incorporated$227.90$25.52B$11.28B$1.02B$9.101.02M
11
LH logo
LH
Labcorp Holdings Inc.$291.02$24.13B$14.14B$941.50M$11.29664.64K
12
GH logo
GH
Guardant Health, Inc.$150.20$19.72B$1.08B-$433.19M$-3.412.96M
13
MEDP logo
MEDP
Medpace Holdings, Inc.$605.82$17.55B$2.68B$460.40M$15.63349.91K
14
ICLR logo
ICLR
ICON Public Limited Company$170.32$13.45B$8.17B$488.67M$6.16868.98K
15
RVTY logo
RVTY
Revvity, Inc.$113.17$12.66B$2.90B$240.96M$2.101.43M
16
CRL logo
CRL
Charles River Laboratories International, Inc.$229.29$11.22B$4.03B-$184.65M$-3.75862.80K
17
QGEN logo
QGEN
Qiagen N.V.$41.45$8.66B$2.10B$402.17M$1.932.91M
18
BLLN logo
BLLN
BillionToOne, Inc.$128.94$6.84B$350.73M$30.66M$0.78720.20K
19
TWST logo
TWST
Twist Bioscience Corporation$92.44$5.70B$409.48M-$81.28M$-1.331.89M
20
SHC logo
SHC
Sotera Health Company$17.49$5.03B$1.19B$117.80M$0.412.82M
21
VCYT logo
VCYT
Veracyte, Inc.$57.88$4.71B$541.74M$88.01M$1.101.30M
22
RDNT logo
RDNT
RadNet, Inc.$60.98$4.70B$2.14B-$14.19M$-0.19933.72K
23
ADPT logo
ADPT
Adaptive Biotechnologies Corporation$22.31$3.47B$295.41M-$49.68M$-0.323.64M
24
GRAL logo
GRAL
GRAIL, Inc.$70.36$2.86B$156.12M-$395.32M$-10.32573.77K
25
CDNA logo
CDNA
CareDx, Inc.$37.61$2.00B$412.82M-$8.19M$-0.151.11M
26
WGS logo
WGS
GeneDx Holdings Corp.$63.38$1.86B$442.68M-$77.81M$-2.63877.05K
27
NEO logo
NEO
NeoGenomics, Inc.$14.24$1.84B$745.97M-$99.21M$-0.963.61M
28
PSNL logo
PSNL
Personalis, Inc.$12.22$1.27B$64.52M-$95.55M$-1.024.87M
29
OPK logo
OPK
OPKO Health, Inc.$1.17$887.89M$581.12M-$212.91M$-0.282.93M
30
CSTL logo
CSTL
Castle Biosciences, Inc.$25.48$761.57M$339.92M-$22.16M$-0.75340.86K
31
FLGT logo
FLGT
Fulgent Genetics, Inc.$19.98$617.00M$320.35M-$73.81M$-2.40275.00K
32
MYGN logo
MYGN
Myriad Genetics, Inc.$5.70$534.09M$829.00M-$399.90M$-4.291.35M
33
PRE logo
PRE
Prenetics Global Limited$19.42$329.80M$113.75M-$71.04M$-4.72234.45K
34
BDSX logo
BDSX
Biodesix, Inc.$22.32$215.52M$96.10M-$31.96M$-3.9387.17K
35
IMDX logo
IMDX
Insight Molecular Diagnostics Inc.$4.96$171.21M$1.95M-$47.84M$-1.46233.83K
36
XGN logo
XGN
Exagen Inc.$4.95$118.08M$68.38M-$20.17M$-0.90225.00K
37
BNR logo
BNR
Burning Rock Biotech Limited$8.95$95.14M$79.65M-$8.17M$-0.7623.78K
38
PRPO logo
PRPO
Precipio, Inc.$22.88$40.80M$25.42M-$922.00K$-0.5670.03K
39
ADVB logo
ADVB
Advanced Biomed Inc.$16.78$21.56M$0.00$5.28M$4.662.97M
40
MDXH logo
MDXH
MDxHealth SA$0.42$21.13M$133.00M-$43.37M$-0.88650.27K
41
QUCY logo
QUCY
Quantum Cyber N.V.$1.11$13.10M$1.18M-$30.07M$-6.774.32M
42
XWEL logo
XWEL
XWELL, Inc.$1.05$7.77M$28.83M-$26.49M$-4.39165.37K
43
MBAI logo
MBAI
Check-Cap Ltd.$1.17$7.29M$0.00-$25.15M$-4.3066.22K
44
NDRA logo
NDRA
ENDRA Life Sciences Inc.$5.23$4.12M$0.00-$9.25M$-9.5947.28K
45
BIAF logo
BIAF
bioAffinity Technologies, Inc.$0.67$3.00M$5.61M-$15.88M$-5.86536.42K
46
ISPC logo
ISPC
iSpecimen Inc.$2.23$7.61K$1.03M-$11.10M$-7.38104.55K

About the Diagnostics & research Industry

The Diagnostics & research industry comprises 46 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

  • - Industry leaders with market share and scale
  • - Growth companies expanding rapidly
  • - Value opportunities below peer averages
  • - Dividend payers for income investors

Key Considerations

  • - Compare valuation ratios to industry peers
  • - Assess competitive positioning and moats
  • - Monitor regulatory and technology trends
  • - Evaluate financial health and cash flow